Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics

Canadian Journal of Veterinary Research

Volumn 65, Issue 4, 2001, Pages 213-222

  Stipkovits, L ^a   Miller, D ^a   Glavits, R ^a   Fodor, L ^a   Burch, D ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORTETRACYCLINE; CYFAC; FUMARIC ACID; HYDROGEN; LINCOMYCIN; PROCAINE PENICILLIN; PULMOTIL G200; SULFADIMIDINE; TIAMULIN; TIAMULIN FUMARATE; TILMICOSIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; LUNG INFECTION; MICROBIOLOGY; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PASTEURELLA MULTOCIDA; RECTUM TEMPERATURE; RESPIRATORY TRACT DISEASE; SEROTYPE; SWINE; WEIGHT GAIN;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; CHLORTETRACYCLINE; DITERPENES; DRUG THERAPY, COMBINATION; MYCOPLASMA; MYCOPLASMA INFECTIONS; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; SWINE DISEASES; TREATMENT OUTCOME; WEIGHT GAIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMATALES; PASTEURELLA MULTOCIDA; SUS SCROFA;

EID: 0035192824     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Proc Symp Mycoplasma pneumonia
2. Scanning electron microscopy of trachea and bronchi from gnotobiotic pigs inoculated with Mycoplasma hyopneumoniae
3. Isolation of a cytopathic factor from Mycoplasma hyopneumoniae
4. Effects of Mycoplasma hyopneumoniae and Actinobacillus (Haemophilus) pleuropneumoniae infections on alveolar macrophage function in swine
5. Immune suppression of Mycoplasma hyopneumoniae infected swine
6. The porcine respiratory disease complex. Are subpopulations important?
7. Porcine viral disease
8. Mycoplasma hyopneumoniae increases the susceptibility of pigs to experimental Pasteurella multocida pneumonia
9. Effect of Mycoplasma hyopneumoniae and Actinobacillus (Haemophilus) pleuropneumoniae infection on alveolar macrophage function in swine
10. The synergistic activity of tiamulin and chlortetracycline in-feed treatment of bacteriologically complicated enzootic pneumonia in fattening pigs
11. Pulse doses cut pneumonia drug costs
12. Dose evaluation studies with Pulmotil (tilmicosin premix, Elanco) in the control of naturally occurring pneumonia in growing/fattening pigs
13. An in vitro investigation of the sensitivity of German field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to SDZ PMD 296, a new pleuromulin derivative
14. Some recommendations concerning primary isolation of Mycoplasma suipneumoniae and Mycoplasma flocculare. A survey
15. Development of polymerase chain reaction primers to detect Mycoplasma hyopneumoniae
16. Mycoplasma suipneumoniae and Mycoplasma hyorhinis demonstrated in pneumonic pig lungs by the fluorescent antibody technique
17. Identification of mycoplasmas by immunofluorescence
18. Actinobacillus pleuropneumoniae
19. Evaluation of a monoclonal blocking ELISA and IHA for antibodies to Mycoplasma hyopneumoniae in SPF-pig herds
20. Top 10 rules for controlling porcine respiratory disease complex
21. M. Hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus induced pneumonia
22. Vaccination as a means of controlling M. hyopneumoniae
23. The efficacy of in-feed antibiotics for prevention of experimentally induced Actinobacillus pleuropneumonia
24. Comparison of efficacy of penethamate ("Leocillin") and tiamulin ("Tiamutin") in experimentally induced Actinobacillus pleuropneumoniae (A.pp) infection in pigs
25. In vitro susceptibility of 108 isolated Actinobacillus pleuropneumoniae strains to 17 antimicrobial agents from pigs in Italy in 1994-95
26. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic
27. Tilmicosin pharmacokinetics in healthy swine
28. Efficacy of Aureomycin chlortetracycline granular premix against experimental Mycoplasma hyopneumoniae challenge
29. Efficacy of combinations of Econor and chlortetracycline for Streptococcus suis, Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Mycoplasma hyopneumoniae isolates in Korea